Angelidi: Difference between revisions
Jump to navigation
Jump to search
(Created page with "{{WIP}} {{Infobox company | name = Angelidi A.E. | logo = Angelidi logo.svg | type = Public | traded_as = | ISIN...") |
No edit summary |
||
| Line 39: | Line 39: | ||
Angelidi engages in the research and development, manufacturing and marketing of pharmacological products, principally in the prescription market, but the firm also develops over-the-counter medications. The corporation covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis, and vaccines | Angelidi engages in the research and development, manufacturing and marketing of pharmacological products, principally in the prescription market, but the firm also develops over-the-counter medications. The corporation covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis, and vaccines | ||
{{RAX | {{RAX companies}} | ||
Latest revision as of 12:16, 8 March 2023
 | This article is incomplete because it is pending further input from participants, or it is a work-in-progress by one author. Please comment on this article's talk page to share your input, comments and questions. Note: To contribute to this article, you may need to seek help from the author(s) of this page. |
 | |
| Public | |
| Industry |
|
| Founded | 1915 |
| Headquarters | Constantinoupoli, Romaia |
Area served | Worldwide |
Key people | TBD |
| Products | Medications, generic drugs, over-the-counter drugs, vaccines, diagnostics, contact lenses, animal health |
| Website | angelidi.ra |
Angelidi A.E. is a Romaian multinational pharmaceutical and healthcare company headquartered in Constantinoupoli, Romaia. The company was established in 1915. The company is a component of the Constantinoupoli Stock Exchange stock market index.
Angelidi engages in the research and development, manufacturing and marketing of pharmacological products, principally in the prescription market, but the firm also develops over-the-counter medications. The corporation covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis, and vaccines
 RAX companies of Romaia | |
|---|---|
Last updated: 9 November 2022 | |
|